Manny D. Bacolod Department of Microbiology and Immunology Weill Cornell Medical College New York, NY (USA)
Dr. Manny D. Bacolod is currently an Assistant Professor of Microbiology and Immunology at Weill
Cornell Medical College (New York, NY). After earning his Ph.D. in Chemistry from the University of
Connecticut, he has held various research positions at Duke University Medical Center, Weill Cornell
Medical College, Brigham and Women’s Hospital, and Virginia Commonwealth University. Dr.
Bacolod’s contribution to cancer literature encompasses a wide range of topics including colon cancer
genomics and biomarker discovery, epigenetics, cancer genetics, brain tumor drug resistance, chemical
mutagenesis, cancer metastasis, and immuno oncogenomics.
Yonghan He Kunming Institute of Zoology Kunming Institute of Zoology, Chinese Academy of Sciences Kunming (China)
Dr. Yonghan He received his M.D. degree from Harbin Medical University in China. He finished his post-doctoral training at the University of Arkansas for Medical Sciences, and University of Florida in the USA. He is presently serving as an Associate professor of Kunming Institute of Zoology, Chinese Academy of Sciences. Dr. He focuses on studying the mechanisms involved in cancer cell death, and developing small molecules or natural compounds that suppress tumor cell growth. He is also very interested in studying cellular senescence and developing senolytics that can selectively kill senescent cells to improve the health of aged individuals. Dr. He has published more than 50 peer-reviewed papers in journals related to cancer or aging.
Heiko Konig Department of Hematology and Oncology Indiana University Melvin and Bren Simon Cancer Center Indianapolis, IN (USA)
Dr. Heiko Konig is presently serving as an Assistant Professor at the Indiana University Melvin & Bren Simon Cancer Center in Inianapolis where his effort is dedicated to the care of patients with acute myeloid leukemia (AML) and other hematological malignancies, and laboratory based research with a focus on the role of hypoxia in the development of AML drug resistance and minimal residual disease. He received his MD and doctoral degrees from the medical schools at the Ludwig Maximilians University Munich and the Philipps University Marburg/ Germany, respectively. He is also serving as the co-chair of the Big Ten Cancer Research Consortium (BTCRC) Myeloid Malignancies Clinical Trial Working Group and the Hoosier Cancer Research Network (HCRN) Lymphoma/Leukemia Clinical Trial Working Group.
Guangwei Liu Institute of Cell Biology, College of Life Sciences Beijing Normal University Beijing (China)
Dr. Guangwei Liu is currently serving as a professor in the Key Laboratory of Cell Proliferation and Regulation, Ministry of Education, Beijing Normal University, Beijing, China. He and his group members are currently interested in understanding the molecular and cellular mechanisms for positive and negative regulation of T cell immune function, exploring the possibility for clinical application of anti-tumor immunotherapy and anti-infection, as well as establishing protocols to induce transplant immune tolerance. He has contributed more than 70 peer reviewed papers in international journals such as Immunity, Nature Immunology, Nature Communications, PNAS, Blood, Journal of Immunology and Cancer Research.
Valery V. Tuchin Institute of Precision Mechanics and Control of the RAS Saratov State University Saratov (Russia)
Dr. Valery V. Tuchin is presently serving as a Professor and Chair of Optics and Biophotonics at Saratov University (National Research University of Russia). He is also the head of Laboratory of Laser Diagnostics of Technical and Living Systems, Institute of Precision Mechanics and Control, RAS, and the supervisor of Interdisciplinary Laboratory of Biophotonics at Tomsk State University (National Research University of Russia) and Laboratory of FemtoMedicine of ITMO University (National Research University of Russia). His research interests include tissue optics, laser medicine, tissue optical clearing, and nanobiophotonics. He has published more than 700 papers (Web of Science), 27 monographs and text-books, and 58 book chapters. Dr. Tuchin is also a holder of more than 50 patents.
Ruiwen Zhang Center for Drug Discovery University of Houston 3455 Cullen Blvd. Houston, TX 77204 (USA)